Antibody-drug conjugates FDA-approved for patients with ovary and cervical cancers can improve outcomes.
By BECKY GILLETTE
Michael Ulm, MD, a Gynecological Oncologis.... Read More
On Sept. 16, the American Association for Cancer Research released a first-of-its-kind report outlining disparities in outcomes and clinical trial participation for ethnic and.... Read More